Clinical Trials Browser

Phase 3 × INDUSTRY × beta-D-glucosylisophosphoramide mustard × Clear all

NCT01954992 2024-12-31

Glufosfamide Versus 5-FU in Second Line Metastatic Pancreatic Cancer

Phase 3 Recruiting

Gastrointestinal

Metastatic Pancreatic Adenocarcinoma

NCT00099294 2009-04-30

Study of the Efficacy and Safety of Glufosfamide Compared With Best Supportive Care in Metastatic Pancreatic Cancer

Phase 3 Completed

Gastrointestinal

Neoplasm Metastasis, Neoplasms, Pancreatic Neoplasms